Mechanisms of disease: Neurogenetics of MeCP2 deficiency

Nature Clinical Practice Neurology

Volumn 2, Issue 4, 2006, Pages 212-221

  Francke, Uta ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Autism; Chromatin; Congenital encephalopathy; Methyl CpG binding protein 2 (MeCP2); Rett syndrome

Indexed keywords

BINDING PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIN DEPENDENT KINASE 5; DNA; GLUCOCORTICOID; METHYL CPG BINDING PROTEIN 2; PROTEIN SERINE THREONINE KINASE;

AUTISM; BRAIN DISEASE; CHROMATIN; CHROMOSOME DISORDER; DEVELOPMENTAL DISORDER; DISEASE COURSE; DNA DETERMINATION; GENE MUTATION; GENE NUMBER; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GENETIC CODE; GENETIC DISORDER; GENETIC IDENTIFICATION; GENETIC TRANSCRIPTION; GENOME IMPRINTING; GENOTYPE PHENOTYPE CORRELATION; HAPPY PUPPET SYNDROME; HETEROZYGOSITY; HUMAN; KNOCKOUT MOUSE; LANGUAGE DISABILITY; MENTAL DEFICIENCY; MISSENSE MUTATION; MITOSIS; MOLECULAR MECHANICS; MOTOR DYSFUNCTION; MOUSE; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PREDICTION; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN FUNCTION; RECURRENCE RISK; RETT SYNDROME; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SKILL; SYNAPSE; X CHROMOSOME INACTIVATION; X CHROMOSOME LINKAGE;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MODELS, BIOLOGICAL; RETT SYNDROME; SEX FACTORS;

EID: 33645355913     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0148     Document Type: Review

References (77)

1. Rett A (1966) Uber ein eigenartiges hirnatrophisches Syndrom bei Hyperammonamie im Kindesalter. Wien Med Wochenschr 116: 723-738
2. Einspieler C et al. (2005) Abnormal general movements in girls with Rett disorder: The first four months of life. Brain Dev 27 (Suppl 1): S8-S13
3. Schanen NC et al. (1997) A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map. Am J Hum Genet 61: 634-641
4. Schanen NC and Francke U (1998) A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map. Am J Hum Genet 63: 267-269
5. Sirianni N et al. (1998) Rett syndrome: Confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am J Hum Genet 63: 1552-1558
6. Amir RE et al. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185-188
7. Wan M et al. (1999) Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotpots. Am J Hum Genet 65: 1520-1529
8. Ravn K et al. (2005) Large genomic rearrangements in MECP2. Hum Mutat 25: 324
9. Mnatzakanian GN et al. (2004) A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 36: 339-341
10. Kriaucionis S and Bird A (2004) The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res 32: 1818-1823
11. Amir RE et al. (2005) Mutations in axon 1 of MECP2 are a rare cause of Rett syndrome. J Med Genet 42: E15
12. Hoffbuhr K et al. (2001) MeCP2 mutations in children with and without the phenotype of Rett syndrome. Neurology 56: 1486-1495
13. Weaving LS et al. (2003) Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype. Am J Med Genet A 118: 103-114
14. Huppke P et al. (2002) Influence of mutation type and location on phenotype in 123 patients with Rett Syndrome. Neuropediatrics 33: 63-68
15. Colvin L et al. (2004) Refining the phenotype of common mutations in Rett syndrome. J Med Genet 41: 25-30
16. Smeets E et al. (2005) Rett syndrome in females with CTS hot spot deletions: A disorder profile. Am J Med Genet A 132: 117-120
17. Shibayama A et al. (2004) MECP2 structural and 3′-UTR variants in schizophrenia, autism and other psychiatric diseases: A possible association with autism. Am J Med Genet B Neuropsychiatr Genet 128: 50-53
18. Imessaoudene B et al. (2001) MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J Med Genet 38: 171-174
19. Hitchins MP et al. (2004) Investigation of UBE3A and MECP2 in Angelman syndrome (AS) and patients with features of AS. Am J Med Genet A 125: 167-172
20. Kleefstra T et al. (2004) MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics. Eur J Hum Genet 12: 24-28
21. Maiwald R et al. (2002) De novo MECP2 mutation in a 46,XX male patient with Rett syndrome. Neurogenetics 4: 107-108
22. Clayton-Smith J et al. (2000) Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet 356: 830-832
23. Topcu M et al. (2002) Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eur J Hum Genet 10: 77-81
24. Villard L et al. (2000) Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology 55: 1188-1193
25. Zeev BB et al. (2002) Rett syndrome: Clinical manifestations in males with MECP2 mutations. J Child Neurol 17: 20-24
26. Lynch SA et al. (2003) Sporadic case of fatal encephalopathy with neonatal onset associated with a T158M missense mutation in MECP2. Arch Dis Child Fetal Neonatal Ed 88: F250-252
27. Leuzzi V et al. (2004) Early-onset encephalopathy and cortical myoclonus in a boy with MECP2 gene mutation. Neurology 63: 1968-1970
28. Meloni I et al. (2000) A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet 67: 982-985
29. Yntema HG et al. (2002) Low frequency of MECP2 mutations in mentally retarded males. Eur J Hum Genet 10: 487-490
30. Ylisaukko-Oja T et al. (2005) MECP2 mutation analysis in patients with mental retardation. Am J Med Genet A 132: 121-124
31. Van Esch H et al. (2005) Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 77: 442-453
32. Evans JC et al. (2005) Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum Genet 13: 1113-1120
33. Tate P et al. (1996) The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nature Genet 12: 205-208
34. Chen RZ et al. (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27: 327-331
35. Guy J et al. (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27: 322-326
36. Shahbazian M et al. (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35: 243-254
37. Luikenhuis S et al. (2004) Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc Natl Acad Sci USA 101: 6033-6038
38. Collins AL et al. (2004) Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 13: 2679-2689
39. Traynor J et al. (2002) Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Med Genet 3: 12
40. Ronnett GV et al. (2003) Olfactory biopsies demonstrate a defect in neuronal development in Rett's syndrome. Ann Neurol 54: 206-218
41. Shahbazian MD et al. (2002) Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11: 115-124
42. Jung BP et al. (2003) The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J Neurobiol 55: 86-96
43. Nagai K et al. (2005) A transcriptional repressor MeCP2 causing Rett syndrome is expressed in embryonic non-neuronal cells and controls their growth. Brain Res Dev Brain Res 157: 103-106
44. Kishi N and Macklis JD (2004) MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 27: 306-321
45. Matarazzo V et al. (2004) The transcriptional repressor Mecp2 regulates terminal neuronal differentiation. Mol Cell Neurosci 27: 44-58
46. Lewis JD et al. (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69: 905-914
47. Nan X et al. (1997) MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88: 471-481
48. Kokura K et al. (2001) The Ski protein family is required for MeCP2-mediated transcriptional repression. J Biol Chem 276: 34115-34121
49. Harikrishnan KN et al. (2005) Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet 37: 254-264
50. Klose RJ and Bird AP (2004) MeCP2 behaves as an elongated monomer that does not stably associate with the Sin3a chromatin remodeling complex. J Biol Chem 279: 46490-46496
51. Fuks F et al. (2003) The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res 31: 2305-2312
52. Kimura H and Shiota K (2003) Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J Biol Chem 278: 4806-4812
53. Jeffery L and Nakielny S (2004) Components of the DNA methylation system of chromatin control are RNA-binding proteins. J Biol Chem 279: 49479-49487
54. Buschdorf JP and Stratling WH (2004) A WW domain binding region in methyl-CpG-binding protein MeCP2: Impact on Rett syndrome. J Mol Med 82: 135-143
55. Young JI et al. (2005) Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci USA 102: 17551-17558
56. von Kries JP et al. (1991) A matrix/scaffold attachment region binding protein: Identification, purification, and mode of binding. Cell 64: 123-135
57. Chandler SP et al. (1999) The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry 38: 7008-7018
58. Georgel PT et al. (2003) Chromatin compaction by human MeCP2: Assembly of novel secondary chromatin structures in the absence of DNA methylation. J Biol Chem 278: 32181-32188
59. Horike S et al. (2005) Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 37: 31-40
60. Razin A and Shemer R (1999) Epigenetic control of gene expression. Results Probl Cell Differ 25: 189-204
61. Balmer D et al. (2002) MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum Genet 110: 545-552
62. Kimura MI et al. (2004) Dlx5, the mouse homologue of the human-imprinted DLX5 gene, is biallelically expressed in the mouse brain. J Hum Genet 49: 273-277
63. Samaco RC et al. (2005) Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet 14: 483-492
64. Makedonski K et al. (2005) MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum Mol Genet 14: 1049-1058
65. Gartler SM et al. (2004) Normal histone modifications on the inactive X chromosome in ICF and Rett syndrome cells: Implications for methyl-CpG binding proteins. BMC Biol 2: 21
66. Colantuoni C et al. (2001) Gene expression profiling in postmortem Rett syndrome brain: Differential gene expression and patient classification. Neurobiol Dis 8: 847-865
67. Tudor M et al. (2002) Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci USA 99: 15536-15541
68. Ballestar E et al. (2005) The impact of MECP2 mutations in the expression patterns of Rett syndrome patients. Hum Genet 116: 91-104
69. Stancheva I et al. (2003) A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. Mol Cell 12: 425-435
70. Chen WG et al. (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302: 885-889
71. Martinowich K et al. (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302: 890-893
72. Chang Q et al. (2006) The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49: 341-348
73. Gorski JA et al. (2003) Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci 23: 6856-6865
74. Salama-Cohen P et al. (2005) NGF controls dendrite development in hippocampal neurons by binding to p75NTR and modulating the cellular targets of Notch. Mol Biol Cell 16: 339-347
75. Armstrong DD (1995) The neuropathology of Rett syndrome - overview 1994. Neuropediatrics 26: 100-104
76. Belichenko PV et al. (2005) Dendritic alterations in the brains of mouse models of Rett syndrome. In Proceedings of the RSRF 6th Annual Rett Syndrome Symposium, 2005 June 27-29; Itasca, IL
77. Nuber UA et al. (2005) Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum Mol Genet 14: 2247-2256